Osteo-odonto-keratoprosthesis

Last updated
Osteo-odonto-keratoprosthesis
Specialty ophthalmology

Osteo-odonto-keratoprosthesis (OOKP), also known as "tooth in eye" surgery, [1] is a medical procedure to restore vision in the most severe cases of corneal and ocular surface patients. It includes removal of a tooth from the patient or a donor. [2]

Contents

After removal, a longitudinal lamina is cut from the tooth and a hole is drilled perpendicular to the lamina. The hole is then fitted with a cylindrical lens. The lamina is grown in the patients' cheek for a period of months and then is implanted upon the eye.

The procedure was pioneered by the Italian ophthalmic surgeon Professor Benedetto Strampelli in the early 1960s. Strampelli was a founder-member of the International Intra-Ocular Implant Club (IIIC) in 1966. [3]

Medical uses

An operation to graft the OOKP is undertaken in severe pemphigoid, chemical burns, Stevens–Johnson syndrome, trachoma, Lyell syndrome and multiple corneal graft failure. [4]

There is a significant risk of anatomical failure of lamina in the long term, estimated at 19% in a small study, [5] with the main risks being laminar resorption, particularly in allografts, and glaucoma.

Another, bigger study comparing OOKP with the lesser known osteo-keratoprosthesis (OKP) in 145 and 82 patients and follow-up terms up to 10 years yielded the following statistics:[ citation needed ]

Another long-term study of 181 patients puts the chances of retaining an intact OOKP after 18 years at 85%. [7]

In 2022, a retrospective study conducted on 82 eyes with OOKP using original Strampelli technique, showed an anatomical survival of 94% up to 30 years of follow-up. The same study also reported a visual acuity better than 1.00 logMAR (or 20/200 Snellen) at 10 years in 81% of the eyes, and a visual acuity of 1.21 logMAR (or 20/324 Snellen) at 30 years. [8]

Procedure

OOKP is a two-stage operation: [9]

Stage 1 of the surgery involves five separate procedures:

  1. The eye is opened up and the entire inner surface of the eyelids, corneal surface and all scar tissue is removed
  2. Inner mucosal lining of the cheek is transplanted onto the new surface of the eye
  3. A canine or premolar tooth and part of the adjacent bone and ligaments are removed
  4. A bolt-shaped structure is fashioned from the tooth-bone complex which is fitted with a plastic optical cylinder
  5. The tooth-bone-cylinder complex is implanted into the patient's cheek to grow a new blood supply

Stage 2 (about 4 months later) involves two separate procedures:

  1. The cheek mucosal lining over the eye is opened and the inner contents of the eye are removed
  2. The tooth-bone-cylinder complex is removed from the cheek and inserted into the eye, the mucosal cheek lining is replaced over the implant.

At the end of the procedure, light can now enter through the plastic cylinder, and the patient is able to see through this cylinder with good vision. [3]

History

The procedure was pioneered by the Italian ophthalmic surgeon Professor Benedetto Strampelli[ citation needed ] in Rome in the early 1960s.

The son of the geneticist and agronomist Nazareno Strampelli, Benedetto Strampelli held the chair of ophthalmic surgery at Rome's Ospedale di San Giovanni in Laterano where he was one of the first surgeons in Italy to transplant cornea. In 1953 he was the first Italian to implant intraocular lens which were manufactured to his own design by Rayners in UK. Strampelli was a founder-member with Harold Ridley and Peter Choyce of the International Intra-Ocular Implant Club (IIIC) in 1966.[ citation needed ]

See also

Related Research Articles

<span class="mw-page-title-main">Ophthalmology</span> Field of medicine treating eye disorders

Ophthalmology is a clinical and surgical specialty within medicine that deals with the diagnosis and treatment of eye disorders. A former term is oculism.

<span class="mw-page-title-main">Keratoconus</span> Medical condition involving the eye

Keratoconus (KC) is a disorder of the eye that results in progressive thinning of the cornea. This may result in blurry vision, double vision, nearsightedness, irregular astigmatism, and light sensitivity leading to poor quality-of-life. Usually both eyes are affected. In more severe cases a scarring or a circle may be seen within the cornea.

<span class="mw-page-title-main">LASIK</span> Corrective ophthalmological surgery

Laser-Assisted in Situ Keratomileusis (LASIK), commonly referred to as laser eye surgery or laser vision correction, is a type of refractive surgery for the correction of myopia, hyperopia, and an actual cure for astigmatism, since it is in the cornea. LASIK surgery is performed by an ophthalmologist who uses a laser or microkeratome to reshape the eye's cornea in order to improve visual acuity.

<span class="mw-page-title-main">Eye surgery</span> Surgery performed on the eye or its adnexa

Eye surgery, also known as ophthalmic surgery or ocular surgery, is surgery performed on the eye or its adnexa. Eye surgery is part of ophthalmology and is performed by an ophthalmologist or eye surgeon. The eye is a fragile organ, and requires due care before, during, and after a surgical procedure to minimize or prevent further damage. An eye surgeon is responsible for selecting the appropriate surgical procedure for the patient, and for taking the necessary safety precautions. Mentions of eye surgery can be found in several ancient texts dating back as early as 1800 BC, with cataract treatment starting in the fifth century BC. It continues to be a widely practiced class of surgery, with various techniques having been developed for treating eye problems.

<span class="mw-page-title-main">Radial keratotomy</span> Refractive surgical procedure to correct myopia (nearsightedness

Radial keratotomy (RK) is a refractive surgical procedure to correct myopia (nearsightedness). It was developed in 1974 by Svyatoslav Fyodorov, a Russian ophthalmologist. It has been largely supplanted by newer, more accurate operations, such as photorefractive keratectomy, LASIK, Epi-LASIK and the phakic intraocular lens.

<span class="mw-page-title-main">Intraocular pressure</span> Fluid pressure inside the eye

Intraocular pressure (IOP) is the fluid pressure inside the eye. Tonometry is the method eye care professionals use to determine this. IOP is an important aspect in the evaluation of patients at risk of glaucoma. Most tonometers are calibrated to measure pressure in millimeters of mercury (mmHg).

<span class="mw-page-title-main">Eye examination</span> Series of tests assessing vision and pertaining to the eyes

An eye examination is a series of tests performed to assess vision and ability to focus on and discern objects. It also includes other tests and examinations pertaining to the eyes. Eye examinations are primarily performed by an optometrist, ophthalmologist, or an orthoptist. Health care professionals often recommend that all people should have periodic and thorough eye examinations as part of routine primary care, especially since many eye diseases are asymptomatic.

<span class="mw-page-title-main">Cataract surgery</span> Removal of opacified lens from the eye

Cataract surgery, also called lens replacement surgery, is the removal of the natural lens of the eye that has developed a cataract, an opaque or cloudy area. The eye's natural lens is usually replaced with an artificial intraocular lens (IOL) implant.

<span class="mw-page-title-main">Corneal transplantation</span> Surgical procedure of repairing corneal tissue to treat corneal blindness

Corneal transplantation, also known as corneal grafting, is a surgical procedure where a damaged or diseased cornea is replaced by donated corneal tissue. When the entire cornea is replaced it is known as penetrating keratoplasty and when only part of the cornea is replaced it is known as lamellar keratoplasty. Keratoplasty simply means surgery to the cornea. The graft is taken from a recently deceased individual with no known diseases or other factors that may affect the chance of survival of the donated tissue or the health of the recipient.

<span class="mw-page-title-main">Phthisis bulbi</span> Shrunken, non-functional eye

Phthisis bulbi is a shrunken, non-functional eye. It may result from severe eye disease, inflammation or injury, or it may represent a complication of eye surgery. Treatment options include insertion of a prosthesis, which may be preceded by enucleation of the eye.

<span class="mw-page-title-main">Ocular prosthesis</span> Type of craniofacial prosthesis

An ocular prosthesis, artificial eye or glass eye is a type of craniofacial prosthesis that replaces an absent natural eye following an enucleation, evisceration, or orbital exenteration. The prosthesis fits over an orbital implant and under the eyelids. Though often referred to as a glass eye, the ocular prosthesis roughly takes the shape of a convex shell and is made of medical grade plastic acrylic. A few ocular prostheses today are made of cryolite glass. A variant of the ocular prosthesis is a very thin hard shell known as a scleral shell which can be worn over a damaged or eviscerated eye. Makers of ocular prosthetics are known as ocularists. An ocular prosthesis does not provide vision; this would be a visual prosthesis. Someone with an ocular prosthesis is altogether blind on the affected side and has monocular vision.

ReLExSmall incision lenticule extraction (SMILE), second generation of ReLEx Femtosecond lenticule extraction (FLEx), is a form of laser based refractive eye surgery developed by Carl Zeiss Meditec used to correct myopia, and cure astigmatism. Although similar to LASIK laser surgery, the intrastromal procedure uses a single femtosecond laser referenced to the corneal surface to cleave a thin lenticule from the corneal stroma for manual extraction.

<span class="mw-page-title-main">Bromfenac</span> Chemical compound

Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) marketed in the US as an ophthalmic solution by ISTA Pharmaceuticals for short-term, local use. Prolensa and Bromday are the once-daily formulation of bromfenac, while Xibrom was approved for twice-daily administration. In the European Union, the brand name is Yellox. Bromfenac is indicated for the treatment of ocular inflammation and pain after cataract surgery.

<span class="mw-page-title-main">Keratoprosthesis</span> Surgical procedure where a diseased cornea is replaced with an artificial one

Keratoprosthesis is a surgical procedure where a diseased cornea is replaced with an artificial cornea. Traditionally, keratoprosthesis is recommended after a person has had a failure of one or more donor corneal transplants. More recently, a less invasive, non-penetrating artificial cornea has been developed which can be used in more routine cases of corneal blindness. While conventional cornea transplant uses donor tissue for transplant, an artificial cornea is used in the keratoprosthesis procedure. The surgery is performed to restore vision in patients with severely damaged cornea due to congenital birth defects, infections, injuries and burns.

<span class="mw-page-title-main">Gholam A. Peyman</span> Iranian-American ophthalmologist and retina surgeon known for inventing LASIK eye surgery

Gholam A. Peyman is an Iranian American ophthalmologist, retina surgeon, and inventor. He is best known for his invention of LASIK eye surgery, a vision correction procedure designed to allow people to see clearly without glasses. He was awarded the first US patent for the procedure in 1989.

Blast-related ocular trauma comprises a specialized subgroup blast injuries which cause penetrating and blunt force injuries to the eye and its structure. The incidence of ocular trauma due to blast forces has increased dramatically with the introduction of new explosives technology into modern warfare. The availability of these volatile materials, coupled with the tactics of contemporary terrorism, has caused a rise in the number of homemade bombs capable of extreme physical harm.

Bascom Palmer Eye Institute is the University of Miami School of Medicine's ophthalmic care, research, and education center. The institute is based in the Health District of Miami, Florida, and has been ranked consistently as the best eye hospital and vision research center in the nation.

The Intra-Ocular Implant Club was founded in 1966 by the English ophthalmic surgeons Sir Harold Ridley and Peter Choyce, to promote research in the field of intraocular lens (IOL) implantation. At that time there was widespread opposition in the ophthalmic surgery profession to the use of IOLs. The founders saw the club as a forum to allow free and unhindered exchange of ideas about IOLs and implantation surgical techniques. From the outset it was international in its membership and it set itself a parental and advisory role for the then nascent national societies to develop in each country for intraocular implant surgeons. However, this global role was only acknowledged in the name change in July 1975, when the Intra-Ocular Implant Club became The International Intra-Ocular Implant Club (IIIC).

<span class="mw-page-title-main">Corneal opacity</span> Medical condition

Corneal opacification is a term used when the human cornea loses its transparency. The term corneal opacity is used particularly for the loss of transparency of cornea due to scarring. Transparency of the cornea is dependent on the uniform diameter and the regular spacing and arrangement of the collagen fibrils within the stroma. Alterations in the spacing of collagen fibrils in a variety of conditions including corneal edema, scars, and macular corneal dystrophy is clinically manifested as corneal opacity. The term corneal blindness is commonly used to describe blindness due to corneal opacity.

<span class="mw-page-title-main">Peter Szurman</span> German ophthalmologist

Peter Szurman is a German ophthalmologist, scientist, and professor of ophthalmology in Sulzbach/Saar.

References

  1. "TOOTH-IN-EYE (OOKP) SURGERY HELP 8 REGAIN SIGHT". www.ndc.com.sg. Archived from the original on 2008-03-04.
  2. Guidera, Anita (28 February 2008). "Son's tooth helps save dad's sight". Irish Independent.
  3. 1 2 National Dental Centre - 25 May 2005 TOOTH-IN-EYE (OOKP) SURGERY HELP 8 REGAIN SIGHT Archived 4 March 2008 at the Wayback Machine
  4. Viitala R, Franklin V, Green D, Liu C, Lloyd A, Tighe B (January 2009). "Towards a synthetic osteo-odonto-keratoprosthesis". Acta Biomater . 5 (1): 438–52. doi:10.1016/j.actbio.2008.07.008. PMID   18706878.
  5. Liu C, Okera S, Tandon R, Herold J, Hull C, Thorp S (September 2008). "Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis: results from the UK". Br J Ophthalmol . 92 (9): 1211–7. doi:10.1136/bjo.2007.130567. PMID   18511541. S2CID   26716899.
  6. Michael R, Charoenrook V, de la Paz MF, Hitzl W, Temprano J, Barraquer RI (August 2008). "Long-term functional and anatomical results of osteo- and osteoodonto-keratoprosthesis". Graefes Arch. Clin. Exp. Ophthalmol. 246 (8): 1133–7. doi:10.1007/s00417-008-0850-3. PMID   18491123. S2CID   13019199.
  7. Falcinelli G, Falsini B, Taloni M, Colliardo P, Falcinelli G (October 2005). "Modified osteo-odonto-keratoprosthesis for treatment of corneal blindness: long-term anatomical and functional outcomes in 181 cases". Arch. Ophthalmol. 123 (10): 1319–29. doi:10.1001/archopht.123.10.1319. PMID   16219722.
  8. Iannetti L, Liberali M, Armentano M, Alisi L, Visioli G, Mastromarino D, Edoardo B, Iannetti G (May 2022). "Osteo-odonto-keratoprosthesis according to Strampelli original technique: A retrospective study with up to 30 years of follow-up". Am J Ophthalmol . 242: 56–68. doi:10.1016/j.ajo.2022.05.015. hdl: 11573/1635748 . PMID   35618023. S2CID   249035286.
  9. Ricci R, Pecorella I, Ciardi A, Della Rocca C, Di Tondo U, Marchi V (April 1992). "Strampelli's osteo-odonto-keratoprosthesis. Clinical and histological long-term features of three prostheses". Br J Ophthalmol . 76 (4): 232llll–4. doi:10.1136/bjo.76.4.232. PMC   504235 . PMID   1390492.